These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8497341)

  • 41. Failed oocyte retrieval after lack of human chorionic gonadotropin administration in assisted reproductive technology.
    Asch RH; Li HP; Yovich JL; Katayama KP; Balmaceda JP; Rojas FJ; Stone SC
    Fertil Steril; 1992 Aug; 58(2):361-5. PubMed ID: 1633903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early pituitary desensitization and ovarian suppression with leuprolide acetate is associated with in vitro fertilization-embryo transfer success.
    Seifer DB; Thornton KL; DeCherney AH; Lavy G
    Fertil Steril; 1991 Sep; 56(3):500-4. PubMed ID: 1909977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Timed unilateral ovarian follicular aspiration prior to administration of human chorionic gonadotrophin for the prevention of severe ovarian hyperstimulation syndrome in in-vitro fertilization: a prospective randomized study.
    Egbase PE; Makhseed M; Al Sharhan M; Grudzinskas JG
    Hum Reprod; 1997 Dec; 12(12):2603-6. PubMed ID: 9455821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Area under the curve for estradiol levels do not consistently reflect estradiol levels on the day of hCG administration in patients undergoing controlled ovarian hyperstimulation for IVF-ET.
    Mitwally MF; Bhakoo HS; Crickard K; Sullivan MW; Batt RE; Yehl J
    J Assist Reprod Genet; 2005 Feb; 22(2):57-63. PubMed ID: 15844730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cetrotide confirmatory trial of cetrorelix/0.25 mg in 26 women undergoing ovarian stimulation with recombinant follicle stimulating hormones for IVF, ICSI and embryo transfer (ET).
    Mettler L; Brandenburg K
    Clin Exp Obstet Gynecol; 2000; 27(2):103-5. PubMed ID: 10968345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
    Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
    Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of transvaginal color Doppler ultrasonography of the ovarian artery as a predictor of ovarian response in controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer.
    Kim SH; Ku SY; Jee BC; Suh CS; Moon SY; Lee JY
    J Assist Reprod Genet; 2002 Mar; 19(3):103-12. PubMed ID: 12005303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Results of in vitro fertilization and embryo transfer in women with infertility due to genital tuberculosis.
    Gurgan T; Urman B; Yarali H
    Fertil Steril; 1996 Feb; 65(2):367-70. PubMed ID: 8566264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of GnRH analog for induction of the ovulatory surge of gonadotropins in patients at risk of the ovarian hyperstimulation syndrome.
    Kulikowski M; Wołczyński S; Kuczyński W; Grochowski D; Szamatowicz M
    Gynecol Endocrinol; 1995 Jun; 9(2):97-102. PubMed ID: 7502696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
    Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
    J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elevated E2: oocyte ratio in women undergoing IVF and tubal ET. Correlation with a decrease in the implantation rate.
    Yang JH; Chen HF; Lien YR; Chen SU; Ho HN; Yang YS
    J Reprod Med; 2001 May; 46(5):434-8. PubMed ID: 11396368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial.
    Prapas Y; Ravanos K; Petousis S; Panagiotidis Y; Papatheodorou A; Margioula-Siarkou C; Iuliano A; Gullo G; Prapas N
    J Assist Reprod Genet; 2017 Nov; 34(11):1537-1545. PubMed ID: 28776117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Severe ovarian hyperstimulation syndrome after combined GnRH-agonist and low-dose human chorionic gonadotropin trigger in a patient with a single kidney.
    Pereira N; Lekovich JP; Kligman I; Rosenwaks Z
    Gynecol Endocrinol; 2017 Aug; 33(8):593-597. PubMed ID: 28440686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of highly purified FSH (metrodin-high purity) with pergonal for IVF superovulation.
    Bagratee JS; Lockwood G; López Bernal A; Barlow DH; Ledger WL
    J Assist Reprod Genet; 1998 Feb; 15(2):65-9. PubMed ID: 9513843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hormonal profiles in successful and unsuccessful implantation in IVF-ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support.
    Balasch J; Creus M; Fábregues F; Carmona F; Casamitjana R; Peñarrubia J; Rivera F; Vanrell JA
    Gynecol Endocrinol; 1995 Mar; 9(1):51-8. PubMed ID: 7793300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome.
    Benadiva CA; Davis O; Kligman I; Moomjy M; Liu HC; Rosenwaks Z
    Fertil Steril; 1997 Apr; 67(4):724-7. PubMed ID: 9093201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduction of human menopausal gonadotropin dose before coasting prevents severe ovarian hyperstimulation syndrome with minimal cycle cancellation.
    Aboulghar MA; Mansour RT; Serour GI; Rhodes CA; Amin YM
    J Assist Reprod Genet; 2000 May; 17(5):298-301. PubMed ID: 10976419
    [No Abstract]   [Full Text] [Related]  

  • 59. Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.
    Huang FJ; Chang SY; Tsai MY; Kung FT; Wu JF; Chang HW
    J Assist Reprod Genet; 2001 Feb; 18(2):91-6. PubMed ID: 11285987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibin and estradiol responses to ovarian hyperstimulation: effects of age and predictive value for in vitro fertilization outcome.
    Hughes EG; Robertson DM; Handelsman DJ; Hayward S; Healy DL; de Kretser DM
    J Clin Endocrinol Metab; 1990 Feb; 70(2):358-64. PubMed ID: 2298853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.